Cita APA

Jing, C., Fu, Y., Yi, Y., Zhang, M., Zheng, S., Huang, J., . . . Zhang, B. (2019). HHLA2 in intrahepatic cholangiocarcinoma: An immune checkpoint with prognostic significance and wider expression compared with PD-L1. J Immunother Cancer.

Chicago Style Citation

Jing, Chu-Yu, et al. "HHLA2 in Intrahepatic Cholangiocarcinoma: An Immune Checkpoint With Prognostic Significance and Wider Expression Compared With PD-L1." J Immunother Cancer 2019.

Cita MLA

Jing, Chu-Yu, et al. "HHLA2 in Intrahepatic Cholangiocarcinoma: An Immune Checkpoint With Prognostic Significance and Wider Expression Compared With PD-L1." J Immunother Cancer 2019.